In March 2014, the largest pharma player of India by market capitalization, Sun Pharma, became the latest of the large Indian pharma exporters facing the US-FDA ‘Import Ban’ for drugs manufactured at its Gujarat-based plant. This news came as a … Continue reading
Loss of Ranbaxy, Gain of Big Pharma…And Two Intriguing Coincidences
Reply